These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2289630)

  • 21. Demonstration of specific insulin binding to cytosolic proteins in H35 hepatoma cells, rat liver and skeletal muscle.
    Harada S; Smith RM; Smith JA; Shah N; Jarett L
    Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):21-8. PubMed ID: 7864812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The degradation of [125I]iodoinsulin by cytosol from rat liver and the formation of high-molecular-weight products. A study by gel chromatography.
    Mangnall D
    Int J Biochem; 1984; 16(12):1287-94. PubMed ID: 6397372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation of endocytosed insulin in rat liver is mediated by low-density vesicles.
    Pease RJ; Smith GD; Peters TJ
    Biochem J; 1985 May; 228(1):137-46. PubMed ID: 3890838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease.
    Hamel FG; Peavy DE; Ryan MP; Duckworth WC
    Endocrinology; 1986 Jan; 118(1):328-33. PubMed ID: 3510119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor-mediated 125I-labelled insulin degradation in the rat hepatocyte. Studies using chloroquine.
    Bonser AM; Garcia-Webb P; Bhagat CI
    Aust J Exp Biol Med Sci; 1983 Oct; 61 ( Pt 5)():569-79. PubMed ID: 6362640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
    Misbin RI; Almira EC
    Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell itinerary and metabolic fate of proinsulin in rat liver: in vivo and in vitro studies.
    Desbuquois B; Chauvet G; Kouach M; Authier F
    Endocrinology; 2003 Dec; 144(12):5308-21. PubMed ID: 12970169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification by fast atom bombardment mass spectrometry of insulin fragments produced by insulin proteinase.
    Savoy LA; Jones RM; Pochon S; Davies JG; Muir AV; Offord RE; Rose K
    Biochem J; 1988 Jan; 249(1):215-22. PubMed ID: 3277618
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
    Sonne O; Linde S; Larsen TR; Gliemann J
    Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts.
    Stentz FB; Kitabchi AE; Schilling JW; Schronk LR; Seyer JM
    J Biol Chem; 1989 Dec; 264(34):20275-82. PubMed ID: 2684974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HPLC analysis of insulin degradation products from isolated hepatocytes. Effects of inhibitors suggest intracellular and extracellular pathways.
    Hamel FG; Peavy DE; Ryan MP; Duckworth WC
    Diabetes; 1987 Jun; 36(6):702-8. PubMed ID: 3552802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on the inhibitory effect of bacitracin on 125I-labelled insulin internalization in the rat hepatocyte.
    Bonser AM; Garcia-Webb P; Bhagat CI
    Biochim Biophys Acta; 1983 Jun; 762(3):390-7. PubMed ID: 6849985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification.
    Hamel FG; Mahoney MJ; Duckworth WC
    Diabetes; 1991 Apr; 40(4):436-43. PubMed ID: 2010043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver.
    Wroblewski VJ; Masnyk M; Khambatta SS; Becker GW
    Diabetes; 1992 Apr; 41(4):539-47. PubMed ID: 1607078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
    Ryan MP; Peavy DE; Frank BH; Duckworth WC
    Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of lysosomal inhibitors on 125I-insulin and 125I-asialofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes.
    Ward WF; Moss AL
    Diabetes; 1985 May; 34(5):446-51. PubMed ID: 2580748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uptake and degradation of 125I-labelled high density lipoproteins in rat liver cells in vivo and in vitro.
    Ose L; Ose T; Norum KR; Berg T
    Biochim Biophys Acta; 1979 Sep; 574(3):521-36. PubMed ID: 226159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of some cleavage sites of insulin by insulin proteinase.
    Davies JG; Muir AV; Offord RE
    Biochem J; 1986 Dec; 240(2):609-12. PubMed ID: 3545189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen-presenting B cells.
    Semple JW; Ellis J; Delovitch TL
    J Immunol; 1989 Jun; 142(12):4184-93. PubMed ID: 2656861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin and insulin receptor uptake into rat liver. Chloroquine action on receptor recycling.
    Khan MN; Savoie S; Khan RJ; Bergeron JJ; Posner BI
    Diabetes; 1985 Oct; 34(10):1025-30. PubMed ID: 3899805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.